| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/08/2005 | EP1537117A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents |
| 06/08/2005 | EP1537104A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 06/08/2005 | EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 06/08/2005 | EP1537086A2 Novel phenanthridines |
| 06/08/2005 | EP1537066A2 Improvements in pharmaceutically useful compounds |
| 06/08/2005 | EP1536850A1 Medical device having hydration inhibitor |
| 06/08/2005 | EP1536839A2 Method for treating diseases with omega interferon |
| 06/08/2005 | EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/08/2005 | EP1536834A2 Design of chemokine analogs for the treatment of human diseases |
| 06/08/2005 | EP1536833A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 06/08/2005 | EP1536832A2 Flagellin peptides as adjuvants for vaccines |
| 06/08/2005 | EP1536831A2 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 06/08/2005 | EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1536813A2 Compositions and methods comprising protein activated receptor antagonists |
| 06/08/2005 | EP1536804A2 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 06/08/2005 | EP1536800A1 Synergistic interaction of abacavir and alovudine |
| 06/08/2005 | EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 06/08/2005 | EP1536795A1 Inverse agonists acting at virus-encoded g protein-coupled receptors |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536777A1 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 06/08/2005 | EP1441769B1 Pharmaceutical formulations containing low concentrations of peroxide for treating or preventing vaginal infections |
| 06/08/2005 | EP1432427B1 Composition of hypochlorous acid and its applications |
| 06/08/2005 | EP1373269B1 Jun kinase inhibitors |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1231925B1 Method and composition for the treatment of adenoviral ocular infections |
| 06/08/2005 | EP1068182B1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one |
| 06/08/2005 | EP1015459B1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 06/08/2005 | EP1007013B1 Parenteral pimaricin as treatment of systemic infections |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | CN1625569A Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1625409A Immunogen preparation of variable peptidic epitopes and preparation method thereof |
| 06/08/2005 | CN1625394A Processes for preparing crystalline and amorphous mupirocin calcium |
| 06/08/2005 | CN1623984A Fused-ring compounds and use thereof as drugs |
| 06/08/2005 | CN1623602A Vaccines |
| 06/08/2005 | CN1623601A Attenuated live vaccine of vibrion from eel |
| 06/08/2005 | CN1623599A Xiaoyao soft capsule and its preparation technology |
| 06/08/2005 | CN1623590A Medicinal preparation for treating cold |
| 06/08/2005 | CN1623583A Soft ointment for treating skin dermatomycosis |
| 06/08/2005 | CN1623573A Biological preparation garlic bactericidal oil pill for gynecopathy use and its manufacturing method |
| 06/08/2005 | CN1623552A Injection preparation containing active component adefuwei or its salt and its preparation method |
| 06/08/2005 | CN1623551A Solid dispersion containing active component adefuwei or its salt and its preparation method |
| 06/08/2005 | CN1623544A Preparation of injection amoxicillin subaton |
| 06/08/2005 | CN1623541A Application of aloelactone in preparation of medicine |
| 06/08/2005 | CN1623539A Milk thistle silybum marianum long effect preparation and its preparation method |
| 06/08/2005 | CN1623533A Drug formulation with controlled release of active ingredient |
| 06/08/2005 | CN1623429A Antivirus bactericidal health-care flowouring powder |
| 06/08/2005 | CN1205220C Novel cyclosporins |
| 06/08/2005 | CN1205211C Pleuromutilin derivatives as antimicrobials |
| 06/08/2005 | CN1204924C Liquid composition of biodegradable block copolymer for drug delivery system and process for preparation thereof |
| 06/08/2005 | CN1204923C Anhydrous topical ski preparation |
| 06/08/2005 | CN1204920C Antifungal medicnie synergist and its prepn and application |
| 06/08/2005 | CN1204917C Complex rhizoma paridis tincture and preparing method thereof |
| 06/08/2005 | CN1204915C Chinese medicine capsule for treating virus cold and its prodn. method |
| 06/08/2005 | CN1204899C Chinese medicine (instant particles) for treating intractable tined and its preparing process |
| 06/08/2005 | CN1204897C Licorice polysaccharide powder-injection |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/08/2005 | CN1204881C Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection and correlation diseases |
| 06/08/2005 | CN1204875C Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 06/08/2005 | CN1204870C Dental care compositions |
| 06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
| 06/07/2005 | US6903210 Octenidine dihydrochloride, C1 to C8-alkyl alcohol, alkylpolyglycoside non-ionic and quaternary betaine cationic surfactants, water, alpha-hydroxycarboxylic acid |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903132 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903125 Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6902906 Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902748 Medicines manufactured from old platycodon extracts |
| 06/07/2005 | US6902727 Synergistic mixture of polyacrolein and isothiazolin-3-one compounds |
| 06/07/2005 | CA2464258C Compositions containing piperacillin and tazobactam useful for injection |
| 06/07/2005 | CA2332686C Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates |
| 06/07/2005 | CA2244139C Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 06/07/2005 | CA2225439C Propiophenone derivatives and process for preparing the same |
| 06/07/2005 | CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof |
| 06/07/2005 | CA2186039C New oral pharmaceutical dosage form |
| 06/07/2005 | CA2068790C Antiviral compounds |
| 06/02/2005 | WO2005049007A1 Prevention and measures for viral infection |
| 06/02/2005 | WO2005035528A3 Triazole derivatives as antibacterial agents |
| 06/02/2005 | WO2005023270A3 Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
| 06/02/2005 | WO2005009463A3 Antigen-presenting cell vaccines and methods of use thereof |
| 06/02/2005 | WO2005007681A3 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/02/2005 | WO2004112762A3 Pharmaceutical formulations of amyloid inhibiting compounds |
| 06/02/2005 | WO2004103986A3 3-desoxyanthocyanidine compounds and uses thereof as antimicrobial agents |
| 06/02/2005 | WO2004098500A3 CARBACEPHEM ss-LACTAM ANTIBIOTICS |
| 06/02/2005 | US20050119482 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 06/02/2005 | US20050119344 Based on the different degree of protection that ensure the blood-vessels of the healthy and of the tumor tissue against the influence of blood-coagulation enhancing substances; formic (methane) acid; antiseptic and bactericide |
| 06/02/2005 | US20050119338 Combination of cytochome p450 dependent protease inhibitors |
| 06/02/2005 | US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 06/02/2005 | US20050119317 such as (5RS)-3-(3-Fluoro-4-thiomorpholin-4-yl phenyl)-5-(1,2,3-triazol-1-ylmethyl)-4,5-dihydroisoxazole; antibiotics |
| 06/02/2005 | US20050119313 Aqueous antiseptic based on bispyridiniumalkanes |
| 06/02/2005 | US20050119310 nucleoside / nucleitide antiviral agents [2'-deoxy-3'-thiocytidine-5'-triphosphate (3TC)]; immunomodulators / immunostimulants; synergistic effect; prevent drug resistance; reduce toxicity |
| 06/02/2005 | US20050119294 Preparation of 1H-imidazo [4,5-c] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 06/02/2005 | US20050119292 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO) |
| 06/02/2005 | US20050119286 Beta-2'-or 3'-halonucleosides |